摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

dithiophenoxyphosphoryl chloride | 273387-14-7

中文名称
——
中文别名
——
英文名称
dithiophenoxyphosphoryl chloride
英文别名
[Chloro(phenylsulfanyl)phosphoryl]sulfanylbenzene
dithiophenoxyphosphoryl chloride化学式
CAS
273387-14-7
化学式
C12H10ClOPS2
mdl
——
分子量
300.77
InChiKey
HKMPVJRRMRUHIV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    17
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    67.7
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    dithiophenoxyphosphoryl chloride吡啶四氮唑 、 triisopropylbenzenesulfonyl chloride 、 乙酸酐溶剂黄146亚硝酸异戊酯 作用下, 以 吡啶 为溶剂, 反应 91.0h, 生成 N1-[5''-O-(phenylthio)phosphoryl-2''-deoxy-3''-O-allyl-D-lyxitol-2''-yl]-5'-O-phosphoryl-2',3'-di-O-acetylinosine
    参考文献:
    名称:
    Syntheses and Calcium-Mobilizing Evaluations of N-Glycosyl-Substituted Stable Mimics of Cyclic ADP-Ribose
    摘要:
    Cyclic ADP-ribose (cADPR) is not only a potent endogenous calcium modulator but also a second messenger. However, studies on the mechanism of cADPR action were limited due to its instability and lack of available structural modifications in the N-1-glyosyl unit of cADPR. In the present work, a series of N-1-glycosyl mimics with different configurational glycosyls or an ether strand were designed and synthesized mimicking the furanose ring. S(N)2 substitutions were carried out between the protected inosine and glycosyl triflates to form the N-1-glycosylinosine derivatives, accompanied with some O-6-glyeosyl-substituted as side products. The intramolecular cyclization was followed the strategy described by Matsuda et al. It was found that the 8-unsubstituted substrate could also be used to construct the intramolecular cyclic pyrophosphate. The activities of NI-glycosyl-substituted cADPR mimics were evaluated by induced Ca2+ release in rat brain microsomes and HeLa cells. It was found that the configuration of the N-1-glycosyl moiety in cADPR is not a critical structural factor for retaining the activity of mobilizing Ca2+ release. More interestingly, the N-1-acyclic analogue 6 exhibited strong activity by inducing Ca2+ release in both rat brain microsomes and HeLa cells. It constitutes a useful tool for further studies.
    DOI:
    10.1021/jm010530l
  • 作为产物:
    描述:
    苯硫酚sodium hydroxide三氯氧磷 作用下, 以 甲苯 为溶剂, 反应 1.5h, 以3.4 g的产率得到dithiophenoxyphosphoryl chloride
    参考文献:
    名称:
    Autocleavage ofO-Isopropylidene ProtectedO-Phosphono- andO- Thionophosphono Esters of Sugars
    摘要:
    Phosphorylation of D-glucose, D-galactose, D-fructose, glycerol and xylitol acetals with diethoxy- or diphenoxy(thiono)phosphoryl chloride gave the corresponding esters. A novel method of partially and fully deprotecting these compounds, which we have called "autocatalytic cleavage", was effected by simply refluxing in water. Antifungal and insecticidal properties of these compounds are presented.
    DOI:
    10.1080/07328300008544073
点击查看最新优质反应信息

文献信息

  • ADP-ribosyl-N3: A Versatile Precursor for Divergent Syntheses of ADP-ribosylated Compounds
    作者:Lingjun Li、Qianqian Li、Shengqiang Ding、Pengyang Xin、Yuqin Zhang、Shenlong Huang、Guisheng Zhang
    DOI:10.3390/molecules22081346
    日期:——
    play important roles in a series of complex physiological procedures. The design and synthesis of artificial ADP-ribosylated compounds is an efficient way to develop valuable chemical biology tools and discover new drug candidates. However, the synthesis of ADP-ribosylated compounds is currently difficult due to structural complexity, easily broken pyrophosphate bond and high hydrophilicity. In this paper
    腺苷二磷酸核糖 (ADP-核糖) 及其衍生物在一系列复杂的生理过程中发挥着重要作用。人工 ADP 核糖基化化合物的设计和合成是开发有价值的化学生物学工具和发现新候选药物的有效方法。然而,由于结构复杂、焦磷酸键易断裂和高亲水性,ADP-核糖基化化合物的合成目前很困难。本文首次设计合成了ADP-核糖基-N3。以 ADP-核糖基-N3 作为关键前体,开发了一种不同的后修饰策略来制备结构多样化的 ADP-核糖基化化合物,包括带有 ADP-核糖基部分的新型核苷酸和肽。
  • [EN] MACROCYCLIC IMMUNOMODULATORS
    申请人:ABBOTT LABORATORIES
    公开号:WO1993004680A1
    公开(公告)日:1993-03-18
    (EN) Immunomodulatory macrocylic compounds having the formula (VII) and pharmaceutically acceptable salts, esters, amides and prodrugs thereof, wherein X is selected from one of the formulae (Ia), (Ib) and (Ic), as well as pharmaceutical compositions containing the same.(FR) Composés macrocycliques immunomodulateurs répondant à la formule (VII) et pro-médicaments, amides, esters et sels pharmaceutiquement acceptables de ces composés, dans laquelle X est choisi parmi l'une des formules suivantes : (Ia), (Ib) et (Ic), et compositions pharmaceutiques les contenant.
    (EN) 具有公式(VII)和药学上可接受的盐,酯,酰胺和前药的免疫调节大环化合物,其中X从公式(Ia),(Ib)和(Ic)中选择,以及含有相同化合物的药物组合物。 (FR) Composés macrocycliques immunomodulateurs répondant à la formule (VII) et pro-médicaments, amides, esters et sels pharmaceutiquement acceptables de ces composés, dans laquelle X est choisi parmi l'une des formules suivantes : (Ia), (Ib) et (Ic), et compositions pharmaceutiques les contenant.
  • MACROCYCLIC IMMUNOMODULATORS
    申请人:ABBOTT LABORATORIES
    公开号:EP0638082A1
    公开(公告)日:1995-02-15
  • EP0638082A4
    申请人:——
    公开号:EP0638082A4
    公开(公告)日:1994-06-09
  • FLAME RETARDANT
    申请人:Hahn Klaus
    公开号:US20110245360A1
    公开(公告)日:2011-10-06
    A flame retardant comprising a) at least one sulfur compound of the formula (I) A 1 -(Z 1 ) m —(S) n —(Z 2 ) p -A 2 (I) where the definitions of the symbols and indices are as follows: A 1 and A 2 are identical or different, being C 6 -C 12 -aryl, cyclohexyl, Si(OR a ) 3 , a saturated, partially unsaturated, or aromatic, mono- or bicyclic ring having from 3 to 12 ring members and comprising one or more heteroatoms from the group of N, O, and S, where the system is unsubstituted or has substitution by one or more substituents of the group of O, OH, S, SH, COOR b , CONR c R d , C 1 -C 18 -alkyl, C 1 -C 18 -alkoxy, C 1 -C 18 -thioalkyl, C 6 -C 12 -aryl, C 6 -C 12 -aryloxy, C 2 -C 18 -alkenyl, C 2 -C 18 -alkenoxy, C 2 -C 18 -alkynyl, and C 2 -C 18 -alkinoxy; Z 1 and Z 2 are identical or different, being —CO— or —CS—; R a is C 1 -C 18 -alkyl; R b , R c , and R d are identical or different, being H, C 1 -C 18 -alkyl, C 6 -C 12 -aryl, or an aromatic, mono- or bicyclic ring having from 3 to 12 ring members and comprising one or more heteroatoms from the group of N, O, and S; m and p are identical or different, being 0 or 1, and n is a natural number from 2 to 10, and b) at least one halogen-free organophosphorus compound having phosphorus content in the range from 5 to 80% by weight, based on the phosphorus compound, is particularly suitable for protecting foams based on styrene polymers.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐